Effect of phosphodiesterase inhibitors in the bladder
Many aging men will experience lower urinary tract symptoms (LUTS). Phosphodiesterase type 5 (PDE5) inhibitors have shown promise in treating LUTS in these patients. PDE5 inhibitors mediate their effects through several pathways including cAMP, NO/cGMP, K-channel modulated pathways, and the l-cystei...
Saved in:
| Main Authors: | Bilal Chughtai, Aizaz Ali, Claire Dunphy, Steven A. Kaplan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2015-01-01
|
| Series: | Asian Journal of Urology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2214388215000387 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of overactive bladder symptoms in women with Diunorm®: preliminary results report
by: S. V. Shkodkin, et al.
Published: (2021-07-01) -
Editorial: Cyclic nucleotide phosphodiesterases (PDEs) signaling in the endocrine system
by: Federica Campolo, et al.
Published: (2025-01-01) -
Roles of Cyclic Nucleotide Phosphodiesterases in Signal Transduction Pathways in the Nematode <i>Caenorhabditis elegans</i>
by: Kranti K. Galande, et al.
Published: (2025-07-01) -
Diverse Roles of the Multiple Phosphodiesterases in the Regulation of Cyclic Nucleotide Signaling in <i>Dictyostelium</i>
by: Pundrik Jaiswal, et al.
Published: (2025-04-01) -
Chenodeoxycholic acid improves oocyte maturation and embryo quality during bisphenol A exposure by activating the EGFR-ERK1/2 signaling pathway
by: Zhi-Yong An, et al.
Published: (2025-09-01)